MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits

Clinical and Experimental Metastasis

Volumn 18, Issue 7, 2000, Pages 553-560

  Tester, Angus M ^a   Ruangpanit, Neeracha ^a   Anderson, Robin L ^b   Thompson, Erik W ^a,c  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

EMT; Epithelio mesenchymal transition; Mammary; Metastasis; MMP 2 activation; MT1 MMP; Murine; TIMP 2; Vimentin

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MATRIGEL; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VIMENTIN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CELL MIGRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; MESENCHYME; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; ENZYME ACTIVATION; EPITHELIUM; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MESODERM; METALLOENDOPEPTIDASES; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 0034787967     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011953118186     Document Type: Article

References (53)

1. Metalloproteinases and their inhibitors in tissue remodeling
2. The role of urokinase-type plasminogen activator in aggressive tumour cell behavior
3. Regulation of lysosomal endopeptidases in malignant neoplasia
4. Basement membrane and the invasive activity of metastatic tumour cells
5. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
6. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer
7. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor induced host response
8. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in human colon cancer
9. The epithelial to mesenchymal transition and metastatic progession in carcinomas
10. Osteolytic bone metastasis in breast cancer
11. Quantitative selectivity of contact mediated intercellular communication in a metastatic mouse mammary tumor line
12. A novel orthotopic model of breast cancer metastasis to bone
13. Human breast cancer cell metastasis to long bone and soft organs of nude mice: A quantitative assay
14. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats
15. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor
16. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells
17. A matrix metalloproteinase expressed on the surface of invasive tumor cells
18. Type IV collagenases in tumor invasion and metastasis
19. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
20. Membrane-type-matrix metalloproteinase
21. Absence of cell adhesion molecule uvomorulin expression in invasive human breast cancer cell lines
22. Association of increased basement invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
23. An overview of epithelio-mesenchymal transformation
24. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays
25. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells
26. Invasive phenotype of MCF-10A cells over expressing c-Ha-ras and c-erbB-2 oncogenes
27. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
28. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)
29. Degradation of entactin by matrix metalloproteinases: Susceptibility to matrilysin and identification of cleavage sites
30. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
31. Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin and trypsin(ogen) in lung neoplasms: An immmunohistochemical study
32. Sequential production and activation of matrix metalloproteinase -9 (MMP-9) with breast cancer progression
33. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cells
34. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis
35. Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma
36. r 92,000 type collagenase is increased in plasma of patients with colon cancer and breast cancer
37. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion
38. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
39. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells
40. MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production
41. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
42. Matrix metalloproteinase 3 (stomelysin) activates the precursor for the human matrix metalloproteinase 9
43. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
44. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells
45. Regulation of 92 kDa gelatinase B activity in the extracellular matrix by tissue kallikrein
46. Intermolecular autocatalytic cleavage can contribute to the activation of progelatinase A by cell membranes
47. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and PUMP-1 is accompanied by the tissue inhibitor of matrix metalloproteinases
48. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
49. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small lung carcinoma
50. r 72,000 type IV collagenase in normal and malignant human fibroblastoid cells
51. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase
52. 3
53. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase